Ampicillin and Sulbactam Injection Recalled Over Sterility Assurance Failure
The FDA is recalling 11,555 bottles of Ampicillin and Sulbactam for Injection due to lack of assurance of sterility. The nationwide recall affects all lots within expiry.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This Class II FDA drug recall involves a sterility assurance failure affecting an injectable medication. No illnesses or injuries are reported in the source. However, lack of sterility assurance for an injectable drug represents a significant risk-of-harm product where injury has not yet been reported, meeting the criteria for Score 3 (High).
Plain-English summary
The FDA is recalling Ampicillin and Sulbactam for Injection, USP 15 grams per Pharmacy Bulk Package, manufactured by Astral SteriTech Private Ltd. for Piramal Critical Care, Bethlehem, PA (NDC 66794-208-15). The recall affects 11,555 bottles, with all lots currently within expiration dates.
The recall was issued due to lack of assurance of sterility. Sterile formulation is a critical requirement for injectable medications.
The product was distributed nationwide throughout the United States. Patients and healthcare providers who have received this medication should contact their pharmacy or healthcare facility for guidance regarding affected stock.
The recalled product
- Product
- Ampicillin and Sulbactam for Injection, USP 15 grams per Pharmacy Bulk Package, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017 USA, NDC 66794-208-15
- Manufacturer
- Astral SteriTech Private Ltd.
- Category
- Drug — Injectable / Antibiotic
- Hazard
- sterility-failure
- infection-risk
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27